Skip Ribbon Commands
Skip to main content

Primary Diagnosis

Pulmonary Embolism

Study Purpose

To understand the APT treatment protocol used as SoC across institutions and document changes in practice following the OPTALYSE PE study results

Principal Investigator: Sameh Sayfo, MD

Trial Details

Locations: THHBP & BRMCP

Sponsor: EKOS Corporation/ BTG

IRB Number: 018-169

Trial Status: Active to enrollment

Exclusions:
1. Clinician deems the subject high-risk for catastrophic bleeding
2. Life expectancy < one year

Change in Care: None

Contact Information:

Lucy Knight
469.814.4727
Lucy.Knight@BSWHealth.org

Kathryn Shinn
469.814.4981
Kathryn.Shinn@BSWHealth.org

Full Protocol Title

Retrospective and prospective international EKoSoNic® registry Of the treatment and Clinical OUTcomes of patients with Pulmonary Embolism

Get Detailed Information On Clinicaltrials.gov »

BAYLOR SCOTT & WHITE RESEARCH ​INSTITUTE​​